ArticleScientific reports2025
Metabolite characterization and in vitro antiplasmodial potential assessment of Sonchus arvensis L. callus under glutamine treatment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Induction and Marker Selection of Embryogenic-like Callus from the Hypocotyl ofPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
This study investigates the effects of glutamine supplementation on the morphology, anatomy, biomass, production of secondary metabolites, in-vitro antioxidant, and antiplasmodial activity of Sonchus arvensis L. callus. Callus was induced from leaf explants on Murashige and Skoog (MS) medium supplemented with 1 mg/L 2,4-Dichlorophenoxyacetic acid (2,4-D) and 0.5 mg/L 6-Benzylaminopurine (BAP), and subsequently treated with glutamine (0-350 mg/L). Glutamine supplementation affected callus morphology and anatomy, yielding mainly compact callus types. Gas Chromatography-Mass Spectrometry (GC-MS) analysis revealed a variety of metabolites in the callus extracts. Notably, a total of 51 metabolites were detected only in the glutamine-treated callus. In silico prediction suggested antioxidant and antimalarial potential for probable major compounds, including methyl α-D-glucopyranoside, methyl β-D-glucopyranoside, n-hexadecanoic acid, (9Z,12Z)-9,12-octadecadienoic acid, and stigmasterol. In vitro assays highlight that glutamine supplementation enhanced the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activity by up to two-fold and increased the Plasmodium falciparum inhibition by up to three-fold compared to the control callus, with 250 mg/L glutamine being most effective. These findings provide novel insights into the glutamine's role in S. arvensis L. callus culture and demonstrate its potential to increase the valuable bioactive compounds production, particularly those with antimalarial activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.